Bromperidol decanoate

CAS : 75067-66-2

Ref. 3D-FB31417

Informations sur le produit

• Nom: Bromperidol decanoate
• Synonymes: Decanoic acid 4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl ester, Bromperidol decanoate [USAN:BAN], 4-(4-(p-Bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone decanoate (ester), Decanoic acid, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester, R 46541, Unii-73Lg72M4Lv, 4-(4-Bromophenyl)-1-[4-(4-Fluorophenyl)-4-Oxobutyl]Piperidin-4-Yl Decanoate, 4-(4-Bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl decanoate

Description

Bromperidol decanoate is a long-acting injectable form of the antipsychotic drug Bromperidol. It is used to treat schizophrenia and other psychotic disorders, as well as for the short-term treatment of insomnia. Paliperidone is a selective serotonin antagonist that blocks postsynaptic serotonin receptors. It is structurally related to risperidone, but it has fewer extrapyramidal side effects. Bromperidol decreases the symptoms associated with chronic schizophrenia and also relieves agitation in psychiatric patients. This drug acts by binding to dopamine receptors in the brain and blocking dopamine activity, which reduces psychotic symptoms and improves concentration. The decanoate ester allows for a slow release of bromperidol into the bloodstream over time, while paliperidone is rapidly broken down by enzymes in the liver. Bromperidol has been shown to be safe for use in humans at doses up to 20 mg/kg/day; however, adverse reactions are

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 574.56 g/mol
• Formule: C₃₁H₄₁BrFNO₃
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C31H41BrFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3
• Code InChI: InChIKey=ZINCPWWBSRSXBH-UHFFFAOYSA-N
• SMILES: CCCCCCCCCC(=O)OC1(c2ccc(Br)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1